HHS reaches deal with Bayer on Cipro

December 1, 2001

Issue Date: December 1, 2001

Table of Contents

Anthrax scare sparks public pandemonium and a run on a powerful antibiotic
FDA targets web sites selling unapproved drug
Should the public have access to anthrax vaccine?
During disasters, how much info should be told?
HHS reaches deal with Bayer on Cipro
Protecting the uninsured: Is cost-shifting unethical?
Bioterrorism Watch: Flu or anthrax? First inhalational cases yield clues for clinicians to make the critical call
Bioterrorism Watch: CDC moving quickly on smallpox front

Financial Disclosure: None of the authors or planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients

Shop Now: Search Products

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements

Emergency
Hospital
Clinical
All Access
Help
Search
About Us
Newsletters
FreeCME

The trusted source for healthcare information and CONTINUING EDUCATION.

ACCOUNTS RECEIVABLE

AR@relias.com

MAILING ADDRESS

1010 Sync St., Suite 100

Morrisville, NC 27560-5468

USA

Do Not Sell My Personal Information
Privacy Policy
Terms Of Use
Help
Group Sales

For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

We use cookies to create a better experience. By continuing to use our site, you consent to the use of cookies outlined in our Privacy Policy.

Close Banner